webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

ADC Bioassay

BOC Sciences' assay center is equipped with advanced instruments to provide comprehensive biopharmaceutical analysis services in compliance with the FDA regulatory requirements. Our one-stop system supports the analysis and determination of Antibody-Drug Conjugates (ADCs), which determine drugs' biological activity and provide a series of standardized cellular and biochemical assays.

ADC Drug Activity Detection

Bioassays

Certain antibody-conjugated drugs (ADCs) can be tested in the naked antibody stage, such as glycosylation structure, peptide map, charge heterogeneity, which is more accessible than the conjugated stage. For ADC development, selecting the appropriate quality control methods, quality control items and consumables based on the target attributes is an essential link in helping drugs move from theoretical design to laboratory preparation. In order to ensure the safety, efficiency and quality of the ADCs drug, the drug activity needs to be tested during the development stages, which is also one of the most critical indicators during the development process. Methods for viability detection include in vivo assays, in vitro animal organ assays, biochemical enzyme reaction assays, immunological activity assays and in vitro cell culture assays.

ADC Bioassay Services

Cellular Health Assays

Cellular health plays a vital role in the screening of drugs. During the early stage of drug development, it was common to evaluate whether a drug could efficiently eliminate cell targets. BOC Sciences provides various methods to detect cell viability and cytotoxicity, including the stain exclusion method, fluorescence exclusion method, MTT colorimetric method, Annexin V/PI staining method, etc. In addition, we can also perform cellular health assays according to customer needs.

Drug Effects Detection

Drug effects testing is an important part of product quality control strategy for complex drugs. It is combined with the detection of physicochemical properties to ensure production consistency in the products life cycle. In general, the efficacy determination should reflect the mechanism of action of the products. For multifunctional products, more than one pharmacodynamic test is required to fully grasp its biological activity. BOC Sciences can provide drug effects testing services to evaluate ADCs through antigen binding assays and cell-based functional tests. We can use flow cytometry to test the cell cycle, discover specific drug effects to each cell cycle stage as well as study the overall drug effect toward the targets. Furthermore, high-resolution images can also be used to observe intracellular transport and co-localization.

Cell Detection

Flow cytometry is a laser technique for detecting cell or particle properties. It is a powerful tool for rapid, quantitative and accurate determination of cell characteristics. BOC Sciences can track and locate the intracellular transport of drugs through flow cytometry and fluorescence microscopy. We can provide cell detection methods for development and validation to meet customers' regulatory requirements. We design tailor-made cell detection development solutions based on experimental processes and optimized customer-supplied analytical methods to enhance research.

Our Non-Clinical PK Study

Our mAb Release and Characterization Testing

Quality AttributesTest ItemAssay Methods
IdentificationPeptide Mapping, Charge Heterogeneity, ImmunoassayRP-HPLC, cIEF & CE & IEX-HPLC, Western Blotting, ELISA
Glycan ProfilingSialic Acid Content, N-Glycan ContentHILIC-UPLC, CE
PuritySize HeterogeneityCE-SDS, SEC-GPLC, SDS-PAG
Charge HeterogeneityIEX-HPLC, cIEF, Zeta Potential/Nanosizer
Product-Related ImpuritiesCE, LC-MS/MS
Process-Related Impurities(Protein A, Host cell DNA, HCP)ELISA, QPCR
PotencyBioassay, Binding AssayCell Assay, Antigen Binding ELISA, Biacore, Flow Cytometry
ContentProtein ConcentrationUV, HPLC, BCA
SafetySterility, Bacterial Endotoxin, Abnormal Toxicity (USP-Acute Toxicity, EP-Undue Toxicity)Purification by Filtration and Column, In Vivo Testing (Uses Mouse or Guinea Pig)

Our ADC Analysis Workflow

ADC Analysis Workflow

What Can Our ADCs Bioassays Offer?

References

  1. Giulio Casi, & Dario Neri. Antibody-drug conjugates: basic concepts, examples and future perspectives. J Control Release. 2012, 161(2): 422-8.
  2. Yelena V. Kovtun, & Victor S. Goldmacher. Cell killing by antibody-drug conjugates. Cancer Letters. 2007, 255(2): 232-240.
ADC Characterization Services
* Only for research. Not suitable for any diagnostic or therapeutic use.
Support Documents

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

Purity Guaranteed

≥95%
Purity Guaranteed

Countries/Regions Delivered

20+
Countries/Regions Delivered

Technical Support

24/7
Technical Support

Products In Stock

1,000+
Products In Stock

High-Quality Service

100%
High-Quality Service
Send Inquiry
Verification code
Inquiry Basket